221 related articles for article (PubMed ID: 37733143)
1. Testosterone Replacement Therapy and Cardiovascular Disease: Balancing Safety and Risks in Hypogonadal Men.
Blackwell K; Blackwell M; Blackwell T
Curr Cardiol Rep; 2023 Oct; 25(10):1157-1163. PubMed ID: 37733143
[TBL] [Abstract][Full Text] [Related]
2. State-of-the-Art: a Review of Cardiovascular Effects of Testosterone Replacement Therapy in Adult Males.
Elsherbiny A; Tricomi M; Bhatt D; Dandapantula HK
Curr Cardiol Rep; 2017 Apr; 19(4):35. PubMed ID: 28361372
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular benefits and risks of testosterone replacement therapy in older men with low testosterone.
Chrysant SG; Chrysant GS
Hosp Pract (1995); 2018 Apr; 46(2):47-55. PubMed ID: 29478348
[TBL] [Abstract][Full Text] [Related]
4. EMAS position statement: Testosterone replacement therapy in older men.
Kanakis GA; Pofi R; Goulis DG; Isidori AM; Armeni E; Erel CT; Fistonić I; Hillard T; Hirschberg AL; Meczekalski B; Mendoza N; Mueck AO; Simoncini T; Stute P; van Dijken D; Rees M; Lambrinoudaki I
Maturitas; 2023 Dec; 178():107854. PubMed ID: 37845136
[TBL] [Abstract][Full Text] [Related]
5. Testosterone therapy in hypogonadal patients and the associated risks of cardiovascular events.
Kharaba ZJ; Buabeid MA; Ibrahim NA; Jirjees FJ; Obaidi HJA; Kaddaha A; Khajehkarimoddini L; Alfoteih Y
Biomed Pharmacother; 2020 Sep; 129():110423. PubMed ID: 32570122
[TBL] [Abstract][Full Text] [Related]
6. Effect of Testosterone Replacement Therapy on Sexual Function and Hypogonadal Symptoms in Men with Hypogonadism.
Pencina KM; Travison TG; Cunningham GR; Lincoff AM; Nissen SE; Khera M; Miller MG; Flevaris P; Li X; Wannemuehler K; Bhasin S
J Clin Endocrinol Metab; 2024 Jan; 109(2):569-580. PubMed ID: 37589949
[TBL] [Abstract][Full Text] [Related]
7. Prostate Safety Events During Testosterone Replacement Therapy in Men With Hypogonadism: A Randomized Clinical Trial.
Bhasin S; Travison TG; Pencina KM; O'Leary M; Cunningham GR; Lincoff AM; Nissen SE; Lucia MS; Preston MA; Khera M; Khan N; Snabes MC; Li X; Tangen CM; Buhr KA; Thompson IM
JAMA Netw Open; 2023 Dec; 6(12):e2348692. PubMed ID: 38150256
[TBL] [Abstract][Full Text] [Related]
8. Testosterone treatment is not associated with increased risk of adverse cardiovascular events: results from the Registry of Hypogonadism in Men (RHYME).
Maggi M; Wu FC; Jones TH; Jackson G; Behre HM; Hackett G; Martin-Morales A; Balercia G; Dobs AS; Arver ST; Maggio M; Cunningham GR; Isidori AM; Quinton R; Wheaton OA; Siami FS; Rosen RC;
Int J Clin Pract; 2016 Oct; 70(10):843-852. PubMed ID: 27774779
[TBL] [Abstract][Full Text] [Related]
9. Testosterone Therapy and Risk of Acute Myocardial Infarction in Hypogonadal Men: An Administrative Health Care Claims Study.
Li H; Mitchell L; Zhang X; Heiselman D; Motsko S
J Sex Med; 2017 Nov; 14(11):1307-1317. PubMed ID: 29110802
[TBL] [Abstract][Full Text] [Related]
10. Hypogonadism and Testosterone Therapy: Associations With Cardiovascular Risk.
Maganty A; Osterberg EC; Ramasamy R
Am J Mens Health; 2015 Jul; 9(4):340-4. PubMed ID: 24972716
[TBL] [Abstract][Full Text] [Related]
11. Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy.
Coward RM; Simhan J; Carson CC
BJU Int; 2009 May; 103(9):1179-83. PubMed ID: 19154450
[TBL] [Abstract][Full Text] [Related]
12. Testosterone in men with hypogonadism and high cardiovascular risk, Pros.
Rosano GM; Vitale C; Fini M
Endocrine; 2015 Nov; 50(2):320-5. PubMed ID: 25749966
[TBL] [Abstract][Full Text] [Related]
13. Testosterone therapy and the risk of cardiovascular disease in older, hypogonadal men.
Krishnan S; Aldana-Bitar J; Golub I; Ichikawa K; Shabir A; Bagheri M; Hamidi H; Benzing T; Kianoush S; Budoff MJ
Prog Cardiovasc Dis; 2024; 84():14-18. PubMed ID: 38423237
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular Morbidity and Mortality in Men - Findings From a Meta-analysis on the Time-related Measure of Risk of Exogenous Testosterone.
Fallara G; Pozzi E; Belladelli F; Corsini C; Boeri L; Capogrosso P; Montorsi F; Salonia A
J Sex Med; 2022 Aug; 19(8):1243-1254. PubMed ID: 35753891
[TBL] [Abstract][Full Text] [Related]
15. Testosterone Therapy and Cardiovascular Risk: A Critical Analysis of Studies Reporting Increased Risk.
Khera M; Miner M; Jaffe J; Pastuszak AW
J Sex Med; 2021 Jan; 18(1):83-98. PubMed ID: 33317996
[TBL] [Abstract][Full Text] [Related]
16. Obstructive Sleep Apnea Is Associated With Polycythemia in Hypogonadal Men on Testosterone Replacement Therapy.
Lundy SD; Parekh NV; Shoskes DA
J Sex Med; 2020 Jul; 17(7):1297-1303. PubMed ID: 32307242
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular safety of testosterone replacement therapy in men: an updated systematic review and meta-analysis.
Corona G; Rastrelli G; Sparano C; Carinci V; Casella G; Vignozzi L; Sforza A; Maggi M
Expert Opin Drug Saf; 2024 May; 23(5):565-579. PubMed ID: 38553429
[TBL] [Abstract][Full Text] [Related]
18. An update on heart disease risk associated with testosterone boosting medications.
Corona G; Rastrelli G; Guaraldi F; Tortorici G; Reismann Y; Sforza A; Maggi M
Expert Opin Drug Saf; 2019 Apr; 18(4):321-332. PubMed ID: 30998433
[TBL] [Abstract][Full Text] [Related]
19. Testosterone replacement therapy and cardiovascular events.
Çatakoğlu AB; Kendirci M
Turk Kardiyol Dern Ars; 2017 Oct; 45(7):664-672. PubMed ID: 28990951
[TBL] [Abstract][Full Text] [Related]
20. Injection of testosterone may be safer and more effective than transdermal administration for combating loss of muscle and bone in older men.
Borst SE; Yarrow JF
Am J Physiol Endocrinol Metab; 2015 Jun; 308(12):E1035-42. PubMed ID: 25898953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
